CellaVision AB (publ)

CLVSF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$177$130$148$158
Dep. & Amort.$41$40$40$33
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$15$10-$29-$12
Other Non-Cash-$4$16-$22-$20
Operating Cash Flow$198$196$137$160
Investing Activities
PP&E Inv.-$78-$32-$69-$84
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$1-$0
Inv. Sales/Matur.$2$1$0$0
Other Inv. Act.$0-$55$0$0
Investing Cash Flow-$76-$86-$70-$84
Financing Activities
Debt Repay.-$29-$31-$32-$31
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$54-$54-$48-$18
Other Fin. Act.-$12-$12-$11$0
Financing Cash Flow-$95-$97-$90-$48
Forex Effect$0-$0$1$1
Net Chg. in Cash$28$14-$22$28
Supplemental Information
Beg. Cash$122$108$130$102
End Cash$149$122$108$130
Free Cash Flow$121$110$68$75